Nicolas Carboni

Biography

 Nicolas Carboni is the President of Conectus Alsace inc., a “SATT”, the new kind of TTO created in France in 2012. With a team of 31 people, Conectus is in charge of managing IP and licensing for all public research laboratories in Alsace Region, as well as research collaboration with industry (average 8M€ / year). Conectus also manages a 35M€ “Proof of Concept” fund to speed up tech transfer. Prior to joining Conectus, Nicolas was CEO of Alsace Biovalley, one of the leading biocluster in France, leading the development of the life science sector in the Alsace Region. In that position, Nicolas has led the construction and funding of over 50 public-private R&D programs representing over 120M€ of R&D investment. Before that, Nicolas has lived 13 years in Canada, 10 of which working at the interface of public research and industry ‐ both from the public and private side. During that period, he has worked for the National Research Council of Canada, Universities, the Government of Quebec, as well as large industrial groups. Nicolas has a 20-year experience in innovation management and technology transfer accumulated both in France and in North America. In 1997, he was co‐founder of Bio Artificial Gel Technologies (reached FDA approval in 2008), one of the first spin-offs from Université du Québec à Montréal.

Research Interest

  Cell therapy, small molecules